The University of Manchester, Manchester, United Kingdom
Lancaster University, Lancaster, United Kingdom
Lynda Doward is the European Head of Patient-Centered Outcomes Assessment at RTI-HS. Ms. Doward has over 30 years of experience in patient-reported outcomes research. She provides advice and guidance to pharmaceutical companies, medical personnel, and academic researchers on the incorporation of patient-reported outcomes measurement into pharmaceutical product development strategies, clinical trial design and questionnaire development, translation, adaptation, and validation. Ms. Doward has particular expertise in research design and in the application of both traditional and innovative qualitative and quantitative research methods. She has extensive experience managing large-scale international projects involving a broad range of therapeutic areas, including multiple sclerosis, nonalcoholic steatohepatitis, oncology, Alzheimer's disease (patients and caregivers), depression, ankylosing spondylitis, systemic lupus erythematosus, psoriatic arthritis, osteoarthritis, osteoporosis, chronic obstructive pulmonary disease, asthma, kidney disease, growth hormone deficiency, lipoatrophy, HIV/AIDS, atopic dermatitis, psoriasis, recurrent genital herpes, alcohol and drug addiction, diabetic foot ulcers, venous leg ulcers, ostomy, and bowel cleansing.
Ms. Doward has acted as a member of several international task forces and working groups. She was a member of the Leadership Committee for the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices Task Force, addressing measurement of health state utility values for economic models in clinical studies from 2016 to 2016. She was a lead member of an International Benefit Assessment Taskforce for Outcome Measurement in Multiple Sclerosis from 2004 to 2009, has acted as a consultant to the World Health Organization, and has served as a research advisor to the UK Department of Health and the Arthritis Research Campaign. She also has been an active member of the International Society for Pharmacoeconomic Outcomes Research since 2000, regularly acting as a scientific reviewer and judge at international conferences. Ms. Doward has published widely in peer-reviewed journals and has presented her research at numerous international symposia. She also acts as peer reviewer for Value in Health, Pharmacoeconomics, Quality of Life Research, Rheumatology, Social Science & Medicine, Annals of Rheumatic Diseases, Journal of Investigative Dermatology, and BMC Health Services Research.